May. 14 at 2:42 PM
$CELZ COULD BE ONE CATALYST AWAY FROM A MAJOR MOMENTUM RE-RATE
Creative Medical is tightening right as CELZ-201-DDT Phase 2 results for chronic low-back pain are expected in May 2026.
Key levels on watch:
* Accumulation:
$1.70–
$1.82
* Reaccumulation:
$2.02–
$2.20
* Breakout:
$2.32
* Major Resistance:
$2.72
🎯 Target Zone:
$3.31–
$3.68
The roadmap is simple: hold
$2.02–
$2.20, reclaim
$2.32, attack
$2.72, then eyes on
$3.31+
With Phase 2 results potentially due any day now, volume confirmation could turn this setup from quiet accumulation into a serious catalyst-driven move.
Keep CELZ locked in.
Communicated - Disclaimer:
https://fh.bio/jcoop
Sector Peers:
$VTGN $LCTX $ATHX.X
$PSTV
